Literature DB >> 7652762

Liver transplantation in children with Alagille syndrome--a study of twelve cases.

J Cardona1, D Houssin, F Gauthier, D Devictor, J Losay, M Hadchouel, O Bernard.   

Abstract

Cholestasis associated with Alagille syndrome may, in a few cases, be extremely severe and result in major impairment in the quality of life during early childhood and end up in cirrhosis eventually. We report the results of liver transplantation in 12 children with a severe hepatic form of Alagille syndrome. All children presented with cholestatic jaundice from birth, peculiar facies, stenosis of the peripheral pulmonary artery, and posterior embryotoxon; butterfly-like vertebrae were present in 9 children. At the time of transplantation (mean age 7 years 10 months) refractory pruritus was present in 9 children, xanthoma in 11, and height and weight retardation in 11. Total serum bilirubin ranged from 116 to 322 mumol/L and total serum cholesterol from 3.5 to 29 mmol/L. Systolic right ventricular pressure was moderately raised (36 to 48 mmHg) in 5 children; mean creatinine clearance was 99 ml/min/1.73 m2. Histologic examination of the removed livers showed cirrhosis, severe annular fibrosis, and moderate portal fibrosis in 4 children each. Follow-up in the 11 survivors has ranged from 14 months to 5 1/2 years. All lead normal lives. Pruritus and xanthomas disappeared. Increase in height was observed in 8 of the 10 survivors who had growth retardation prior to transplantation. School level is normal in 4 (median age at LT: 5 yr 9 mo) and below normal in 6 (median age at OLT: 9 yr 9 mo). Liver function tests are normal in 10 children. Mean creatinine clearance is 101 ml/min/1.73 m2. These results indicate that the quality of life can be considerably improved after liver transplantation in children with a severe hepatic form of Alagille syndrome and suggest that it could be carried out before these children attend elementary school.

Entities:  

Mesh:

Year:  1995        PMID: 7652762     DOI: 10.1097/00007890-199508270-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Who needs a liver transplant? (new disease specific indications).

Authors:  A Baker; A Dhawan; N Heaton
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 2.  Alagille syndrome.

Authors:  Michelle Hadchouel
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

3.  Outcome of liver disease in children with Alagille syndrome: a study of 163 patients.

Authors:  P Lykavieris; M Hadchouel; C Chardot; O Bernard
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

4.  Growth of long-term survivors of liver transplantation.

Authors:  R M Viner; J T Forton; T J Cole; I H Clark; G Noble-Jamieson; N D Barnes
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

Review 5.  Nutritional Needs and Support for Children with Chronic Liver Disease.

Authors:  Christine H Yang; Brandon J Perumpail; Eric R Yoo; Aijaz Ahmed; John A Kerner
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

Review 6.  Multidisciplinary Management of Alagille Syndrome.

Authors:  Jagadeesh Menon; Naresh Shanmugam; Mukul Vij; Ashwin Rammohan; Mohamed Rela
Journal:  J Multidiscip Healthc       Date:  2022-02-23

7.  Management of Patients with Alagille Syndrome Undergoing Living Donor Liver Transplantation: A Report of 2 Cases.

Authors:  Odai Jamaan Alqahtani; Riaz Nazeer Ahmad; Abdullah Bakr Abolkhair; Aljazi Dhari Alrashid
Journal:  Am J Case Rep       Date:  2022-08-03

Review 8.  Pulmonary artery pathologies in Alagille syndrome: a meta-analysis.

Authors:  Shi-Min Yuan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2022-08-19       Impact factor: 1.065

9.  Evaluation of quality of life in children six months after liver transplantation.

Authors:  Seyed Mohsen Dehghani; Mohammad Hadi Imanieh; Naser Honar; Mohmood Haghighat; Behrooz Astaneh; Ali Bahador; Seyed Ali Malek-Hosseini
Journal:  Middle East J Dig Dis       Date:  2012-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.